Article
Bausch & Lomb has earned NTIOL status for its SofPort Advanced Optics and SofPort Advanced Optics with Violet Shield lenses.
Rochester, NY-The Centers for Medicare and Medicaid Services has granted new technology IOL (NTIOL) designation to two lenses (SofPort Advanced Optics and SofPort Advanced Optics with Violet Shield, Bausch & Lomb) for their spherical aberration-reducing design.
Based on this new designation, which was effective March 6, Medicare will increase by $50 its reimbursement to ambulatory surgery centers when cataract procedures are performed with either of these lenses.
The NTIOL designation and adjusted payment will remain in effect until Feb. 26, 2011.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.